Alignment Healthcare (ALHC) Current Deferred Revenue (2021 - 2023)

Alignment Healthcare's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $146.3 million for Q3 2023.

• Quarterly Current Deferred Revenue rose 25.33% year-over-year to $146.3 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $146.3 million (up 25.33% YoY) and the FY2022 annual result came in at $308000.0, down 34.33% from the prior year.
• Current Deferred Revenue was $146.3 million for Q3 2023 at Alignment Healthcare, down from $147.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $147.5 million in Q2 2023 and bottomed at $308000.0 in Q4 2022.
• A 3-year average of $92.1 million and a median of $128.9 million in 2022 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue slumped 34.33% — and 2023, when it increased 25.33%.
• Alignment Healthcare's Current Deferred Revenue stood at $469000.0 in 2021, then slumped by 34.33% to $308000.0 in 2022, then soared by 47413.64% to $146.3 million in 2023.
• Business Quant data shows ALHC's Current Deferred Revenue at $146.3 million in Q3 2023, $147.5 million in Q2 2023, and $141.1 million in Q1 2023.